30 phenotypes from 5 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Fermt3tm1.1Efp/Fermt3tm1.1Efp involves: C57BL/6	abnormal platelet activation	J:227094
	abnormal platelet physiology	J:227094
	acanthocytosis	J:227094
	decreased erythrocyte cell number	J:227094
	decreased platelet aggregation	J:227094
	decreased susceptibility to induced thrombosis	J:227094
	normal hematopoietic system phenotype	J:227094
	increased bleeding time	J:227094
	increased leukocyte cell number	J:227094
	normal mortality/aging	J:227094
Fermt3tm1b(KOMP)Wtsi/Fermt3tm1b(KOMP)Wtsi C57BL/6N-Fermt3tm1b(KOMP)Wtsi/J	edema	J:211773
	hemorrhage	J:211773
	preweaning lethality, complete penetrance	J:211773
Fermt3tm1Ref/Fermt3tm1Ref involves: 129S1/Sv * 129X1/SvJ	abnormal erythrocyte morphology	J:145476
	abnormal platelet activation	J:133659
	abnormal thrombosis	J:133659
	anemia	J:145476
	anisopoikilocytosis	J:145476
	decreased erythrocyte cell number	J:145476
	decreased platelet aggregation	J:133659
	gastrointestinal hemorrhage	J:133659
	hemorrhage	J:145476
	increased bleeding time	J:133659
	increased nucleated erythrocyte cell number	J:145476
	internal hemorrhage	J:133659
	intracranial hemorrhage	J:133659
	osteopetrosis	J:133659
	pallor	J:145476
	petechiae	J:133659
	postnatal lethality, complete penetrance	J:133659
Fermt3tm2.1Ref/Fermt3tm2.1Ref Tg(Cd4-cre)1Cwi/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2	abnormal effector T cell morphology	J:203436
	abnormal T cell physiology	J:203436
Fermt3tm2.2Ref/Fermt3tm2.2Ref involves: 129S1/Sv * 129X1/SvJ	abnormal cardiovascular system physiology	J:203436
	abnormal hematopoietic system morphology/development	J:203436
	postnatal lethality	J:203436